Regulatory Toxicology And Pharmacology

Regulatory Toxicology And Pharmacology

监管毒理学和药理学

  • 3区 中科院分区
  • Q1 JCR分区

期刊简介

《Regulatory Toxicology And Pharmacology》是由Academic Press Inc.出版社于1981年创办的英文国际期刊(ISSN: 0273-2300,E-ISSN: 1096-0295),该期刊长期致力于医学:法领域的创新研究,主要研究方向为医学-毒理学。作为SCI、SCIE收录期刊(JCR分区 Q1,中科院 3区),本刊采用OA未开放获取模式(OA占比0.3800...%),以发表医学:法领域等方向的原创性研究为核心(研究类文章占比98.17%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在164篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Regulatory Toxicology And Pharmacology审稿周期约为约3月。该刊近年未被列入国际预警名单,年发文量约164篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 164 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
MEDICINE, LEGAL 医学:法 PHARMACOLOGY & PHARMACY 药学 TOXICOLOGY 毒理学
2区 3区 2区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
MEDICINE, LEGAL 医学:法 PHARMACOLOGY & PHARMACY 药学 TOXICOLOGY 毒理学
3区 3区 3区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
MEDICINE, LEGAL 医学:法 PHARMACOLOGY & PHARMACY 药学 TOXICOLOGY 毒理学
2区 3区 3区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
MEDICINE, LEGAL 医学:法 PHARMACOLOGY & PHARMACY 药学 TOXICOLOGY 毒理学
3区 3区 3区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
MEDICINE, LEGAL 医学:法 PHARMACOLOGY & PHARMACY 药学 TOXICOLOGY 毒理学
3区 4区 4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, LEGAL SCIE Q1 1 / 24

97.9

学科:PHARMACOLOGY & PHARMACY SCIE Q2 95 / 356

73.5

学科:TOXICOLOGY SCIE Q2 28 / 106

74.1

学科:MEDICINE, LEGAL SCIE Q1 3 / 24

89.58

学科:PHARMACOLOGY & PHARMACY SCIE Q1 41 / 356

88.62

学科:TOXICOLOGY SCIE Q1 10 / 106

91.04

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, LEGAL SCIE Q1 1 / 22

97.7

学科:PHARMACOLOGY & PHARMACY SCIE Q2 107 / 352

69.7

学科:TOXICOLOGY SCIE Q2 32 / 106

70.3

学科:MEDICINE, LEGAL SCIE Q1 5 / 22

79.55

学科:PHARMACOLOGY & PHARMACY SCIE Q1 58 / 353

83.71

学科:TOXICOLOGY SCIE Q1 14 / 106

87.26

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, LEGAL SCIE Q1 2 / 23

93.5

学科:PHARMACOLOGY & PHARMACY SCIE Q2 136 / 354

61.7

学科:TOXICOLOGY SCIE Q2 44 / 106

59

学科:MEDICINE, LEGAL SCIE Q2 6 / 23

76.09

学科:PHARMACOLOGY & PHARMACY SCIE Q1 59 / 354

83.47

学科:TOXICOLOGY SCIE Q1 13 / 106

88.21

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:7.2 SJR:1.12 SNIP:1.308
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Toxicology Q1 32 / 131

75%

期刊发文

  • Application of a next generation risk assessment framework, integrated testing strategy defined approaches and read-across for evaluating the skin sensitization potency: Case studies with 5-hydroxymethylfurfural and 5,5′-oxydimethylenebis (2-furfural

    Author: Lin, Ni; Zhang, Jianing; Liu, Ying; Zhang, Fenglan; Wang, Gangli; Yu, Zhenxi; Jin, Hongtao; Lu, Yong

    Journal: REGULATORY TOXICOLOGY AND PHARMACOLOGY. 2026; Vol. 168, Issue , pp. -. DOI: 10.1016/j.yrtph.2026.106056

  • Association between swimming pool attendance and allergic diseases: An updated systematic review and meta-analysi

    Author: Wu, Qingqing; Chen, Xueyu; Ye, Xin; Yan, Yingqi; Ma, Xin; Wang, Yiqian; Liu, Meng; Zhang, Chi; Zhao, Xuezhen; Liu, Yan; Jiao, He; Ji, Long; Yan, Yongheng; Qiao, Jianhong

    Journal: REGULATORY TOXICOLOGY AND PHARMACOLOGY. 2026; Vol. 167, Issue , pp. -. DOI: 10.1016/j.yrtph.2026.106061

  • Relative quantitative data of cosmetics consumption: An online survey in Guangzhou, Chin

    Author: Deng, Junfeng; Wu, Zhen; Lu, Xiaodan; Xian, Xiaoyu; Zheng, Shixiong; Mo, Yunying; Liu, Tianyang; Sun, Siyu; Huang, Shihan; Hong, Ye; Yu, Xingyu; Yijiati, Aliya; Xiao, Chenchen; Zheng, Shuning; Wang, Yue; Yang, Xingfen; Fang, Jihui; He, Zhini

    Journal: REGULATORY TOXICOLOGY AND PHARMACOLOGY. 2026; Vol. 167, Issue , pp. -. DOI: 10.1016/j.yrtph.2026.106058

  • Nonclinical development of advanced therapies: Best practices for translational and regulatory succes

    Author: Zhang, Piyan

    Journal: REGULATORY TOXICOLOGY AND PHARMACOLOGY. 2026; Vol. 166, Issue , pp. -. DOI: 10.1016/j.yrtph.2026.106032

  • A multi-dimensional comparative study of 505(b)(2) NDAs approved by FDA and Class 2 NDAs approved by NMPA from 2017 to 2023: Uncovering trends, characteristics, and regulation of modified new drug

    Author: Fu, Lixia; Dong, Songtao; Xie, Ran; Jia, Guoshu; Zhao, Nan; Xiang, Qian; Ji, Xiwei; Zhao, Xia; Chen, Xiaoyuan; Ma, Lingyue; Cui, Yimin

    Journal: REGULATORY TOXICOLOGY AND PHARMACOLOGY. 2025; Vol. 162, Issue , pp. -. DOI: 10.1016/j.yrtph.2025.105864

  • Mechanism and marker of voriconazole-induced liver injury: insights from a quantitative systems toxicology approac

    Author: Du, Qian; Qiu, Yulan; Yang, Luting; Wang, Chuhui; Teng, Mengmeng; Chen, Jiaojiao; Luo, Yu; Sun, Jinyao; Wang, Taotao; Chen, Siying; Dong, Yalin

    Journal: REGULATORY TOXICOLOGY AND PHARMACOLOGY. 2025; Vol. 162, Issue , pp. -. DOI: 10.1016/j.yrtph.2025.105871

  • Reproductive and developmental toxicity assessment of HSK21542, a novel peripherally-restricted kappa opioid receptor agonist in rats and rabbit

    Author: Gou, Xiaoli; Ye, Qidi; Chen, Bo; Zheng, Yu; Chen, Hongyu; Fan, Litong; Meng, Qingyuan; Zhang, Chen; Lu, Yao; Wang, Ju

    Journal: REGULATORY TOXICOLOGY AND PHARMACOLOGY. 2025; Vol. 159, Issue , pp. -. DOI: 10.1016/j.yrtph.2025.105811

  • Enhanced pre- and postnatal developmental toxicity (ePPND) study in non-human primates: Necessity, strategic approaches, and critical consideration

    Author: Lu, Jing; Dou, Dehu; Wang, Yawen; Shu, Jiaao; Lei, Zhiqi; Huo, Yan; Gong, Xinjiang

    Journal: REGULATORY TOXICOLOGY AND PHARMACOLOGY. 2025; Vol. 159, Issue , pp. -. DOI: 10.1016/j.yrtph.2025.105814